Monte rosa therapeutics to present at the td cowen 45th annual health care conference

Boston, feb. 24, 2025 (globe newswire) -- monte rosa therapeutics, inc. (nasdaq: glue), a clinical-stage biotechnology company developing novel molecular glue degrader (mgd)-based medicines, today announced that markus warmuth, m.d., chief executive officer, will present at the td cowen 45th annual health care conference on monday, march 3, 2025, at 2:30 p.m.

COWN Ratings Summary

COWN Quant Ranking